Nordic Countries Suspend Use of Moderna Covid-19 Vaccine in Young People
October 07 2021 - 6:35AM
Dow Jones News
By Dominic Chopping
Finland on Thursday joined Nordic neighbors Sweden and Denmark
in suspending use of Moderna Inc.'s Covid-19 vaccine in young
people after reports of an increased risk of heart
inflammation.
Finland's Institute for Health and Welfare said it will pause
use of Moderna's vaccine for men under the age of 30, adopting a
similar stance to other Nordic nations over concerns that the
vaccine increases inflammation of both the heart muscle and the
membrane that surrounds the heart.
The move comes after Denmark said Wednesday that it wouldn't
offer under 18s the Moderna vaccine as a precautionary measure,
while Sweden's Public Health Agency also said Wednesday it had
paused use of the vaccine for everyone born in 1991 and later.
Swedish authorities said data point to an increased incidence of
cardiovascular conditions in boys and young men especially, so they
will suspend use of the vaccine until Dec. 1, when an update will
be provided.
"New preliminary analyzes from Swedish and Nordic data sources
indicate that the connection is especially clear when it comes to
Moderna's vaccine Spikevax, especially after the second dose," the
Swedish Public Health Agency said.
"The increase in risk is seen within four weeks after the
vaccination, mainly within the first two weeks."
Norway also said yesterday that it recommends young people under
the age of 18 avoid being jabbed with Moderna's vaccine.
"Men under the age of 30 should also consider choosing
[BioNTech/Pfizer's] Comirnaty when they are to be vaccinated," said
Geir Bukholm, deputy director general at the Norwegian Institute of
Public Health.
Write to Dominic Chopping at dominic.chopping@wsj.com
(END) Dow Jones Newswires
October 07, 2021 06:20 ET (10:20 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Apr 2023 to Apr 2024